Zinc finger protein targeting employs modified DNA-binding proteins creating artificial transcription factors. Engineered zinc fingers direct transcriptional regulation. Gene therapy applications employ targeting precision. Cancer cell selectivity from targeting specificity enhances efficacy. Off-target engagement produces unintended effects.
Regulatory submissions justify targeting rationale. Clinical translation requires safety validation. Biomarker assessment confirms target engagement. Post-approval monitoring identifies off-target effects. Emerging technologies improve specificity.
Protein Engineering
Zinc Finger Protein Targeting
Zinc finger protein targeting uses engineered zinc finger proteins to selectively recognise specific DNA sequences for gene regulation, editing or therapeutic intervention.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →